Literature DB >> 10754309

Methylation of class II trans-activator promoter IV: a novel mechanism of MHC class II gene control.

A C Morris1, W E Spangler, J M Boss.   

Abstract

Inhibition of class II trans-activator (CIITA) expression prevents embryonic trophoblast cells from up-regulating MHC class II genes in response to IFN-gamma. This is thought to be one mechanism of maternal tolerance to the fetal allograft. The CIITA gene is regulated by four distinct promoters; promoter III directs constitutive (B cell) expression, and promoter IV regulates IFN-gamma-inducible expression. Using in vivo genomic footprinting, promoter-reporter analysis, Southern blot analysis, and RT-PCR, we have examined the cause of CIITA silencing in a trophoblast-derived cell line. We report here that methylation of promoter IV DNA at CpG sites in Jar cells prevents promoter occupancy and IFN-gamma-inducible transcription. The inhibition of CpG methylation in Jar cells by treatment with 5-aza-2'-deoxycytidine restores IFN-gamma inducibility to CIITA. This is the first description of an epigenetic mechanism involved in regulation of CIITA and MHC class II gene expression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10754309     DOI: 10.4049/jimmunol.164.8.4143

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  25 in total

Review 1.  Novel mechanisms of class II major histocompatibility complex gene regulation.

Authors:  Michael Radosevich; Santa Jeremy Ono
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

2.  Contrasting effects of IFNα on MHC class II expression in professional vs. nonprofessional APCs: Role of CIITA type IV promoter.

Authors:  Laura Pisapia; Giovanna Del Pozzo; Pasquale Barba; Alessandra Citro; Paul E Harris; Antonella Maffei
Journal:  Results Immunol       Date:  2012-09-27

3.  Chemical and genetic control of IFNγ-induced MHCII expression.

Authors:  Ruud H Wijdeven; Marvin M van Luijn; Annet F Wierenga-Wolf; Jimmy J Akkermans; Peter J van den Elsen; Rogier Q Hintzen; Jacques Neefjes
Journal:  EMBO Rep       Date:  2018-07-18       Impact factor: 8.807

4.  Methylation of CIITA promoter IV causes loss of HLA-II inducibility by IFN-gamma in promyelocytic cells.

Authors:  Andrea De Lerma Barbaro; Alessandro De Ambrosis; Barbara Banelli; Giuseppina Li Pira; Ottavia Aresu; Massimo Romani; Silvano Ferrini; Roberto S Accolla
Journal:  Int Immunol       Date:  2008-10-01       Impact factor: 4.823

5.  In vivo, RFX5 binds differently to the human leucocyte antigen-E, -F, and -G gene promoters and participates in HLA class I protein expression in a cell type-dependent manner.

Authors:  Philippe Rousseau; Krzysztof Masternak; Michal Krawczyk; Walter Reith; Jean Dausset; Edgardo D Carosella; Philippe Moreau
Journal:  Immunology       Date:  2004-01       Impact factor: 7.397

6.  HLA-G gene repression is reversed by demethylation.

Authors:  Philippe Moreau; Gael Mouillot; Philippe Rousseau; Celine Marcou; Jean Dausset; Edgardo D Carosella
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-27       Impact factor: 11.205

7.  Kinetics of a gamma interferon response: expression and assembly of CIITA promoter IV and inhibition by methylation.

Authors:  Ann C Morris; Guy W Beresford; Myesha R Mooney; Jeremy M Boss
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

8.  Decreased major histocompatibility complex class II expression in diffuse large B-cell lymphoma does not correlate with CpG methylation of class II transactivator promoters III and IV.

Authors:  Sarah T Wilkinson; Diane R Fernandez; Shawn P Murphy; Rita M Braziel; Elias Campo; Wing C Chan; Jan Delabie; Randy D Gascoyne; Louis M Staudt; Elaine S Jaffe; Andreas Rosenwald; Lisa M Rimsza
Journal:  Leuk Lymphoma       Date:  2009-11

9.  Class II transactivator (CIITA) deficiency in tumor cells: complicated mechanisms or not?

Authors:  Peter J van den Elsen; Nienke van der Stoep
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

Review 10.  Augmentation of effects of interferon-stimulated genes by reversal of epigenetic silencing: potential application to melanoma.

Authors:  Ernest C Borden
Journal:  Cytokine Growth Factor Rev       Date:  2007-08-06       Impact factor: 7.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.